BATM Advanced Communications Limited's (LON:BVC) Zvi Marom speaks to Proactive London's Katie Pilbeam about their option agreement to sell its NGSoft software and digital services business for nearly US$34mln.
Marom explains that this deal will allow the company to focus on its areas of expertise which are cyber and biomedical. He goes on to discuss their COVID-19 kit which has been tested against the new SARS-CoV-2 variant - the virus that causes COVID-19.
He explains, the results confirm that it is effective in diagnosing this new strain.